1. In this secondary analysis of the RESCUE trial, targeted interleukin 6 (IL-6) ligand inhibition with ziltivekimab was associated with ...
1. Atherosclerotic risk factors associated with stroke later in life were present in children, but not associated with arterial ischemic ...
1. Among symptomatic patients with high low-density lipoprotein cholesterol levels considered high risk for atherosclerotic cardiovascular disease (ASCVD), absence of ...
1. After 16 weeks of treatment, patients who received evinacumab had decreases in low density lipoprotein (LDL) of up to ...
